Latest / Pricing Power Podcast with Fexingo: How Businesses Set Prices, Raise Margins, and Win Customers
How the Pricing of a Single Drug Changed an Entire Industry
In this episode of Pricing Power Podcast, Lucas and Luna examine the dramatic pricing story of Gilead's hepatitis C drug Sovaldi, which launched at $84,000 per course in 2013. They trace how that single price triggered a backlash that reshaped drug pricing across the entire pharmaceutical industry, from Medicare negotiation rules to the rise of pharmacy benefit managers. Specific figures include the $1,000 pill, the 95 percent cure rate, and the 50 percent discount Gilead eventually offered. The hosts discuss the tension between recouping R&D costs and public health access, and how the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.